Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,454.80 -74.92 -0.60%
S&P 500 1,317.82 -2.86 -0.22%
Nasdaq 2,837.53 -1.85 -0.07%
Ticker Volume Price Price Delta
STOXX 50 2,161.87 +5.35 0.25%
FTSE 100 5,351.53 +1.48 0.03%
DAX 6,339.94 +24.05 0.38%
Ticker Volume Price Price Delta
Nikkei 8,580.39 +17.01 0.20%
TOPIX 722.11 -0.14 -0.02%
Hang Seng 18,713.40 +47.01 0.25%
Gold 1,571.20 +0.73%
EUR-USD 1.2579 0.4914%
Nasdaq 2,837.53 -0.07%
DJIA 12,454.80 -0.60%
S&P 500 1,317.82 -0.22%
FTSE 100 5,351.53 +0.03%
STOXX 50 2,161.87 +0.25%
DAX 6,339.94 +0.38%
Oil (WTI) 90.86 +0.22%
U.S. 10-year 1.738% -0.039
BAC:US 7.15 +0.14%
FB:US 31.91 -3.39%
  • Exchange: NASDAQ GS
  • Sector: Consumer, Non-cyclical
  • Industry: Healthcare-Products
  • Sub-Industry: Medical Instruments

AngioDynamics Inc

Add to Portfolio

ANGO:US

12.2000 USD 0.1300 1.05%

As of 20:10:00 ET on 05/25/2012.

Snapshot for AngioDynamics Inc (ANGO)

Open: 12.3500 Day's Range: 12.1299 - 12.4200 Volume: 658,639 Bid: 12.2000
Previous Close: 12.3300 52wk Range: 11.3500 - 16.3900 1-Yr Rtn: -20.62% Ask: 12.2200

Stock Chart for ANGO

No chart data available.
  • ANGO:US 12.2000
  • 1D
  • 1M
  • 1Y
12.3300
Interactive ANGO Chart

Previous Close

Key Statistics for ANGO

Current P/E Ratio (ttm) 32.1053
Estimated P/E (05/2012) 28.8416
Earnings Per Share (USD) (ttm) 0.3800
Est. EPS (USD) (05/2012) 0.4230
Est. PEG Ratio 2.2186
Market Cap (M USD) 424.76
Shares Outstanding (M) 34.82
Enterprise Value (M USD) (ttm) 288.08
Enterprise Value/EBITDA (ttm) 10.13
Price/Book (mrq) 0.7472
Price/Sale (ttm) 1.3888
Dividend Indicated Gross Yield 0.0000
Next Earnings Announcement 07/13/2012
More ANGO Key Statistics mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Financials for ANGO

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)
More ANGO Income Statement Data
  • Total Assets
  • Total Liabilities (M/USD)
  • Debt to Assets (%)
More ANGO Balance Sheet Data
  • Operating
  • Investing
  • Financing (M/USD)
More ANGO Cash Flow Data

Company Profile & Key Executives for ANGO

AngioDynamics, Inc. designs, develops, manufactures, and markets therapeutic and diagnostic devices. The Company's products enable interventional physicians to treat peripheral vascular disease and other non-coronary diseases. AngioDynamic's product lines consist of angiographic catheters, hemodialysis catheters, image guided vascular access products, and thrombolytic products.

Vincent A BucciChairmanJoseph M Devivo "Joe"President/CEO
D Joseph GersukExec VP/CFO/TreasurerStephen J McGillSenior VP/Gen Mgr:Intl
More Company Profile & Key Executives for ANGO

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Advertisements